Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

被引:0
|
作者
Michael O. Meyers
Nancy Klauber-DeMore
David W. Ollila
Keith D. Amos
Dominic T. Moore
Amy A. Drobish
Emily M. Burrows
E. Claire Dees
Lisa A. Carey
机构
[1] University of North Carolina School of Medicine at Chapel Hill,Division of Surgical Oncology, Department of Surgery
[2] University of North Carolina School of Medicine at Chapel Hill,Division of Medical Oncology, Department of Medicine
[3] University of North Carolina School of Medicine at Chapel Hill,The Lineberger Comprehensive Cancer Center
来源
关键词
Breast Cancer; Estrogen Receptor; Trastuzumab; Advanced Breast Cancer; Distant Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2851 / 2857
页数:6
相关论文
共 50 条
  • [21] Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy
    Degerli, Ezgi
    Oztas, Nihan Senturk
    Alkan, Gulin
    Bedir, Sahin
    Derin, Sumeyra
    Valikhanova, Nahida
    Sarac, Betul
    Kacar, Ezgi
    Demirci, Nebi Serkan
    Demirelli, Hulusi Fuat
    Turna, Hande
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (01) : 29 - 38
  • [22] The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation
    Yang, T. Jonathan
    Morrow, Monica
    Modi, Shanu
    Zhang, Zhigang
    Krause, Kate
    Siu, Chun
    McCormick, Beryl
    Powell, Simon N.
    Ho, Alice Y.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S495 - S501
  • [23] The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation
    T. Jonathan Yang
    Monica Morrow
    Shanu Modi
    Zhigang Zhang
    Kate Krause
    Chun Siu
    Beryl McCormick
    Simon N. Powell
    Alice Y. Ho
    Annals of Surgical Oncology, 2015, 22 : 495 - 501
  • [24] Molecular subtypes in patients with breast cancer that received neoadjuvant chemotherapy
    Marta, G.
    Mano, M.
    Oliveira, L.
    Pereira, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S504 - S504
  • [25] Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
    Huang, Liang
    Chen, Sheng
    Yang, Wentao T.
    Shao, Zhiming
    ONCOTARGET, 2017, 8 (24) : 39703 - 39710
  • [26] A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy
    Huang, Zhou
    Shi, Mei
    Wang, Wei-Hu
    Shen, Liang-Fang
    Tang, Yu
    Rong, Qing-Lin
    Zhu, Li
    Huang, Xiao-Bo
    Tie, Jian
    Chen, Jia-Yi
    Zhang, Jun
    Wu, Hong-Fen
    Cheng, Jing
    Liu, Min
    Ma, Chang-Ying
    Wang, Shu-Lian
    Li, Ye-Xiong
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 191 - 197
  • [27] Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy
    McIntosh, SA
    Ogston, KN
    Payne, S
    Miller, ID
    Sarkar, TK
    Hutcheon, AW
    Heys, SD
    AMERICAN JOURNAL OF SURGERY, 2003, 185 (06): : 525 - 531
  • [28] MR imaging phenotypes predict response and recurrence in locally advanced breast cancer treated with neoadjuvant chemotherapy
    Yu, EW
    Hylton, N
    Partridge, S
    Moore, D
    Au, A
    Gibbs, J
    Hwang, ESS
    Ewing, C
    Rugo, H
    Park, J
    Tripathy, D
    Chew, K
    Essermann, LJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S69 - S70
  • [29] INFLUENCE OF MOLECULAR SUBTYPES OF BREAST CANCER ON THE RISK OF LOCOREGIONAL RECURRENCE
    Liubota, R. V.
    Liubota, I.
    Zotov, A.
    Zaychuk, V.
    ANNALS OF ONCOLOGY, 2011, 22 : 48 - 48
  • [30] Pathologic complete response is an independent prognostic factor for locoregional recurrence in locally advanced breast cancer patients after neoadjuvant chemotherapy.
    Chou, Hsu-Huan
    Chen, Shin-Che
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 65 - 66